Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration–Approved Antisense Oligonucleotide Drugs

Drug Metabolism and Disposition(2022)10.1124/dmd.121.000417Source: DataRank Database

Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration–Approved Antisense Oligonucleotide Drugs is a research paper published in Drug Metabolism and Disposition (2022). On theSindex it has a DataRank of 0. It has been cited 103 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access103 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 7.44)OA: bronzeTopics (41)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Sunna Liu,Anna Liu ORCID,Anagha Gogate ORCID,Sreenidhi Nair,Raman Bahal ORCID

Live enrichment

PubMed:35221287 PMC:PMC11022858 OpenAlex:https://openalex.org/W4214717665

NCI NIH HHS

Grant: R01 CA241194

NIGMS NIH HHS

Grant: R35 GM140862

National Institutes of Health

Grant: 5R01CA241194-04

Targeting microRNAs in the tumor microenvironment with pHLIP conjugated next generation chemically modified PNAs

National Institutes of Health

Grant: 5R35GM140862-05

The role of lncRNAs in P450-mediated drug metabolism and drug-induced liver injury

FWCI

7.44

Citation Percentile

1.0%

Influential Citations

Citation Trend

2022

2023

2024

2025

2026

bronzeLicense: Elsevier TDM

journalhttps://dmd.aspetjournals.org/content/dmd/50/6/888.full.pdf

BRONZEhttps://dmd.aspetjournals.org/content/dmd/50/6/888.full.pdf

publisherhttps://dmd.aspetjournals.org/content/dmd/50/6/888.full.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0090955624008043?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0090955624008043?httpAccept=text/plain

Fields of Study

RNA Interference and Gene DeliveryMonoclonal and Polyclonal Antibodies ResearchChronic Myeloid Leukemia TreatmentsMedicineChemistry0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Biological ProductsExonsHumansOligonucleotidesUnited StatesUnited States Food and Drug AdministrationOligonucleotides, AntisenseMorpholinosDrug-Related Side Effects and Adverse Reactions

Keywords

PharmacologyDistribution (mathematics)Food and drug administrationDrugAbsorption (acoustics)ExcretionPharmacokineticsADMEChemistryOligonucleotideIn vivoBiologyBiochemistryBiotechnologyGeneBiological ProductsDrug-Related Side Effects and Adverse ReactionsUnited States Food and Drug AdministrationOligonucleotidesHumansExonsOligonucleotides, AntisenseUnited StatesMorpholinos

Sustainable Development Goals

SDG 3: 3. Good health